First of all they have NOT to my knowledge submitted request for marketing approval. They stated that they planned to sometime in late 2012.

Second, they DID release the results of the phase 3 clinical trials at the Neurology Conference in New Orleans in April 2012.

Personally, I think we are being held hostage by a therapy that is way too expensive for them to market. Remember, follow the dollars and that will get you to the answer every time. Although they had to know this going into this endeavour so what gives?

Am I reading old news or what?